Frank Schippers

1.2k total citations · 1 hit paper
15 papers, 745 citations indexed

About

Frank Schippers is a scholar working on Anesthesiology and Pain Medicine, Critical Care and Intensive Care Medicine and Psychiatry and Mental health. According to data from OpenAlex, Frank Schippers has authored 15 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Anesthesiology and Pain Medicine, 9 papers in Critical Care and Intensive Care Medicine and 6 papers in Psychiatry and Mental health. Recurrent topics in Frank Schippers's work include Anesthesia and Sedative Agents (14 papers), Intensive Care Unit Cognitive Disorders (9 papers) and Epilepsy research and treatment (6 papers). Frank Schippers is often cited by papers focused on Anesthesia and Sedative Agents (14 papers), Intensive Care Unit Cognitive Disorders (9 papers) and Epilepsy research and treatment (6 papers). Frank Schippers collaborates with scholars based in United States, Netherlands and Cyprus. Frank Schippers's co-authors include Thomas Stoehr, Joachim Ossig, Daniel Lorch, Marija Pesic, Virginia D. Schmith, Lauren L. Lohmer, Thomas Stöhr, Keith M. Borkett, David Bernstein and Douglas K. Rex and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and British Journal of Anaesthesia.

In The Last Decade

Frank Schippers

15 papers receiving 710 citations

Hit Papers

Anaesthetic efficacy and postinduction hypotension with r... 2024 2026 2025 2024 10 20 30

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Schippers United States 12 684 370 287 242 133 15 745
Carol Cohane United States 8 429 0.6× 194 0.5× 183 0.6× 190 0.8× 104 0.8× 14 548
C Westmoreland United States 6 450 0.7× 143 0.4× 212 0.7× 177 0.7× 118 0.9× 10 536
V Piat France 7 350 0.5× 119 0.3× 110 0.4× 234 1.0× 96 0.7× 13 428
Laurie J. Antonik United States 3 326 0.5× 176 0.5× 114 0.4× 128 0.5× 55 0.4× 5 358
Henk Rietbergen Austria 10 587 0.9× 202 0.5× 314 1.1× 289 1.2× 145 1.1× 15 638
Paul H. Alfillé United States 11 286 0.4× 197 0.5× 133 0.5× 197 0.8× 134 1.0× 19 553
Lars Gramstad Norway 10 560 0.8× 153 0.4× 256 0.9× 146 0.6× 121 0.9× 17 672
M. E. Prins Austria 7 730 1.1× 238 0.6× 370 1.3× 363 1.5× 186 1.4× 11 800
Y Kamiyama United States 5 419 0.6× 118 0.3× 231 0.8× 150 0.6× 116 0.9× 7 554
Dominic S. Carollo United States 5 288 0.4× 128 0.3× 148 0.5× 125 0.5× 63 0.5× 10 383

Countries citing papers authored by Frank Schippers

Since Specialization
Citations

This map shows the geographic impact of Frank Schippers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Schippers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Schippers more than expected).

Fields of papers citing papers by Frank Schippers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Schippers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Schippers. The network helps show where Frank Schippers may publish in the future.

Co-authorship network of co-authors of Frank Schippers

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Schippers. A scholar is included among the top collaborators of Frank Schippers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Schippers. Frank Schippers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Fechner, J., Kariem El‐Boghdadly, Donat R. Spahn, et al.. (2024). Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trial. Anaesthesia. 79(4). 410–422. 37 indexed citations breakdown →
2.
Schippers, Frank, Thomas Stöhr, & Van‐Anh Dao. (2022). Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials. SHILAP Revista de lepidopterología. 10(4). E378–E385. 9 indexed citations
3.
Stöhr, Thomas, Pieter Colin, Joachim Ossig, et al.. (2021). Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. British Journal of Anaesthesia. 127(3). 415–423. 123 indexed citations
4.
Zhou, Jie, Lauren Lohmer, Joachim Ossig, et al.. (2021). A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation. Clinical and Translational Science. 14(4). 1554–1565. 18 indexed citations
5.
Zhou, Jie, Lauren L. Lohmer, Joachim Ossig, et al.. (2020). Population Pharmacokinetics of Remimazolam in Procedural Sedation With Nonhomogeneously Mixed Arterial and Venous Concentrations. Clinical and Translational Science. 14(1). 326–334. 22 indexed citations
6.
Pesic, Marija, Thomas Stöhr, Joachim Ossig, et al.. (2020). Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials. Drugs in R&D. 20(3). 267–277. 23 indexed citations
7.
Zhou, Jie, Vijay Ivaturi, Lauren L. Lohmer, et al.. (2020). Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. Journal of Clinical Anesthesia. 66. 109899–109899. 74 indexed citations
8.
Rex, Douglas K., Raj Bhandari, Daniel Lorch, et al.. (2020). Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial. Digestive and Liver Disease. 53(1). 94–101. 107 indexed citations
9.
Kleiman, Robert, Börje Darpö, Michael Thorn, Thomas Stoehr, & Frank Schippers. (2020). Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization. British Journal of Clinical Pharmacology. 86(8). 1600–1609. 24 indexed citations
10.
Pesic, Marija, et al.. (2020). Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial. European Journal of Clinical Pharmacology. 76(11). 1505–1516. 33 indexed citations
11.
Lohmer, Lauren L., et al.. (2020). Time‐to‐Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia. The Journal of Clinical Pharmacology. 60(4). 505–514. 55 indexed citations
12.
Schippers, Frank, Marija Pesic, Rob Saunders, et al.. (2020). Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant Users. The Journal of Clinical Pharmacology. 60(9). 1189–1197. 18 indexed citations
13.
Hill, Natasha, Nicholas J. Pastis, Frank Schippers, & Gerard A. Silvestri. (2019). Comparing the Efficacy and Safety of Remimazolam Versus Midazolam Based on Age and ASA Class in Sedation for Bronchoscopy. A1399–A1399. 1 indexed citations
14.
Pastis, Nicholas J., Lonny Yarmus, Frank Schippers, et al.. (2018). Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy. CHEST Journal. 155(1). 137–146. 200 indexed citations
15.
Silvestri, Gerard A., Nicholas J. Pastis, Gregory Feldman, et al.. (2017). Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled Trial of Remimazolam: A New Ultra Short Acting Benzodiazepine for Bronchoscopy. CHEST Journal. 152(4). A739–A739. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026